Desoxyn vs. Lamotrigine: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Desoxyn and Lamotrigine. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 165,468 people who take Desoxyn and Lamotrigine, and is updated regularly.
What is Desoxyn?
Desoxyn has active ingredients of methamphetamine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 903 Desoxyn users. Check the latest studies of Desoxyn.
What is Lamotrigine?
Lamotrigine has active ingredients of lamotrigine. It is often used in bipolar disorder. eHealthMe is studying from 76,638 Lamotrigine users. Check the latest studies of Lamotrigine.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
165,468 people who take Desoxyn and Lamotrigine are studied.
Drugs being compared in this study:
- Desoxyn (methamphetamine hydrochloride)
- Lamotrigine (lamotrigine)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Desoxyn:
- not at all: 3.44 %
- somewhat: 11.07 %
- moderate: 27.86 %
- high: 35.88 %
- very high: 21.76 %
Lamotrigine:
- not at all: 3.23 %
- somewhat: 16.75 %
- moderate: 30.59 %
- high: 32.55 %
- very high: 16.89 %
Want to compare Desoxyn with Lamotrigine?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Alonso-Navarro H, Montes JM, Plaza-Nieto JF, Jiménez-Jiménez FJ, "Cataplexy Possibly Associated With Lamotrigine", Journal of clinical psychopharmacology, 2016 Aug .
- Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .
- Foroughipour M, Farzadfard MT, Aghaee M, Ghabeli-Juibary A, Rezaietalab F, "Methamphetamine Related Radiculopathy: Case Series and Review of Literature", Asia Pacific Journal of Medical Toxicology, 2013 Jun .
- Alonso-Navarro H, Montes JM, Plaza-Nieto JF, Jiménez-Jiménez FJ, "Cataplexy Possibly Associated With Lamotrigine", Journal of clinical psychopharmacology, 2016 Aug .
- Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .
- Foroughipour M, Farzadfard MT, Aghaee M, Ghabeli-Juibary A, Rezaietalab F, "Methamphetamine Related Radiculopathy: Case Series and Review of Literature", Asia Pacific Journal of Medical Toxicology, 2013 Jun .
Related studies
Alternative drugs to, pros and cons of:
- Desoxyn (849 reports)
- Lamotrigine (72,845 reports)
Browse all side effects of Desoxyn:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lamotrigine:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on methamphetamine hydrochloride and lamotrigine (the active ingredients of Desoxyn and Lamotrigine, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Sitagliptin Phosphate cause Food Aversion? - 10 seconds ago
- Drug interactions of Atracurium Besylate and Ephedrine - 13 seconds ago
- Could Sinequan cause Coughing Up Blood? - 23 seconds ago
- Drug interactions of Zomig and Zopiclone - 41 seconds ago
- Hemiplegia and drugs of ingredients of colchicine - 48 seconds ago
- Sleep Terror and drugs of ingredients of dalfampridine - 53 seconds ago
- Could Emtriva cause Nausea And Vomiting? - a minute ago
- Montelukast Sodium and Lens Opacity for Women aged 40-49 - a minute ago
- Montelukast Sodium and Cataract for Women aged 40-49 - a minute ago
- Bactrim Ds and Hyponatraemia for Men aged 60+ - a minute ago